drugset / Trial / NCT01483963
AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
RandomizedParallel-groupOpen-labelTreatment
Summary
The objectives of this study are to assess the safety, effectiveness, and immunogenicity of AA4500 in the treatment of adhesive capsulitis.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Collagenase Clostridium Histolyticum | Protein / enzyme biologic | 0.29 mg | — |
| Subject | Collagenase Clostridium Histolyticum | Protein / enzyme biologic | 0.58 mg | — |